DOI: http://dx.doi.org/10.18203/2349-2902.isj20202844

A comparative clinicopathological study between ultrasonography, mammography, fine needle aspiration cytology and core needle biopsy of breast lump

Arnab Mandal, Pradipta Jana, Sabyasachi Bakshi, Ram Krishna Mandal

Abstract


Background: Early presentation and prompt diagnosis is the essential key in treatment of different variety of neoplastic as well as non-neoplastic breast disease. In this study usefulness of high-resolution ultrasonography (HRUSG), mammography, fine needle aspiration cytology (FNAC) and core needle biopsy in correlation with histopathological pattern, was assessed.

Methods: After matching the criteria, 212 cases, were taken for this prospective, single center, observational study.

Results: Out of 212 cases, 163 (76.88%) were benign lesions, 49 (23.11%) were malignant and 1 (0.47%) were of inflammatory pathology. Benign to malignant breast disease ratio was 3.3:1. Out of 49 malignant cases, 45 (91.83%) were ductal cell carcinoma and 4 (8.16%) was apocrine carcinoma. Maximum numbers of cancer patients were found in the 51-60-year age groups. The sensitivity, specificity, positive predictive value and negative predictive value of mammography in detecting carcinoma breast were 87.76%, 64.71%, 87.76% and 64.71% respectively. The sensitivity, specificity, positive predictive value and negative predictive value of HRUSG in detecting carcinoma breast were 85.71%, 90.18%, 72.41% and 95.45% respectively. Among benign lesions, 47 (28.83%) were diagnosed by mammography and 147 (90.18%) were diagnosed by HRUSG. When these modalities were combined, >95% of the lesions was diagnosed accurately.

Conclusions: Ultra sound used liberally as an adjunct to mammography, increase the cancer detection rate. Core needle biopsy is found more accurate but FNAC have limited value in evaluation of benign breast lump. This study also proves that preoperative categorization of breast lesions is utmost important for management of the patient and this will help to avoid unnecessary surgical treatment.


Keywords


Breast lump, Core needle biopsy, Fine needle aspiration cytology, Mammography, Ultrasonography

Full Text:

PDF

References


Alkabban FM, Ferguson T. Cancer, Breast. In: Stat Pearls. Treasure Island (FL): Stat Pearls Publishing; 2020. Available at: https://www.ncbi.nlm. nih.gov/books/NBK482286/. Accessed on 12th April 2020.

Perry MC. Breast Lump. In: Walker HK, Hall WD, Hurst JW, editors. Clinical methods: The history, physical, and laboratory examinations. Chapter 170. 3rd edition. Boston: Butterworths; 1990.

Bailey and Love; Benign breast disease. Short practice of surgery. 27th edition. CRC Chapter 53; 2018.

Schmitt SJ. Benign breast disease and breast cancer risk morphology and beyond. Am J Surg Pathol. 2003;27:836-41.

Hill DA, Preston Martin S, Ross RK, Bernstein L. Medical radiation, family history of cancer and benign breast disease in relation to breast cancer risk in young women in U.S.A. Cancer Causes Control. 2002;13:711-8.

Webb PM, Byrne C, Schmitt SJ, Connolly JL, Jacobs T, Piero G, et al. Family history of breast cancer, age and benign breast disease. Int J Cancer. 2002;100:375-8.

Hindle WH, Payne PA, Pan EY. The use of fine needle aspiration in the evaluation of persistent palpable dominant breast masses. Am J Obstet Gynaecol. 1993;168:1815-9.

Tan KP, Azlan ZM, Rumaisa MP, Murni MRSA, Radhika S, Nurismah MI, et al. The comparative accuracy of ultrasound and mammography in the detection of breast cancer. Med J Malaysia. 2014;69(2):79-85.

Tiwari PK, Ghosh S, Agrawal VK. Diagnostic accuracy of mammography and ultrasonography in assessment of breast cancer. IJCMER. 2017;4:81-3.

Brown AL, Phillips J, Slanetz PJ, Fein-Zachary V, Venkataraman S, Dialani V, et al. Clinical value of mammography in the evaluation of palpable breast lumps in women 30 years old and older. Am J Roentgenol. 2017;209(4):935-42.

Kolb TM, Lichy J. Newhouse JH Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiol. 2002;225:165-75.

Yang WT, Mok CO, King W. Tang A, Metreweli C. Role of high frequency ultrasonography in the evaluation of palpable breast masses in Chinese women: alternative to mammography? J Ultrasound Med. 1996;15(9):637-44.

Chen DR, Chang RF, Huang UL. Breast cancer diagnosis using self-organizing map for soography; Elsevier. 2000;26(3):405-11.

Lingaraju N, Narashimhaswamy P, Mohan RM, Venkatesh N. Evaluation of palpable breast lumps under the age of 35 years with triple assessment. Int J Sci Stud. 2016;4(1):10-5.

Saha A, Mukhopadhyay M, Das C, Sarkar K, Saha AK, Sarkar DKR. FNAC versus core needle biopsy: a comparative study in evaluation of palpable breast lump. JCDR. 2016;10(2):EC05-EC08.

Giri S. Efficacy of fine needle aspiration cytology in evaluation of breast lumps: a one year study. IJCRR. 2013;5(6):114-18.

Hua Y, Wei W, Liu JL. Diagnostic value of fine needle aspiration biopsy for breast mass: a systematic review and meta-analysis. BMC Cancer. 2012;12(1):41.

Kamphausen BH, Toellner T, Ruschenburg I. The value of ultrasound-guided fine-needle aspiration cytology of the breast: 354 cases with histoligical correlation. Anticancer Res. 2003;23(3C):3009-13.

White RR, Halperin TJ, Olson JA, Soo MS, Bentley RC, Seigler HF. Impact of core-needle breast biopsy on the surgical management of mammographic abnormalities. Ann Surg. 2001;233(6):769-77.

Ballo MS, Sneige N. Can core needle biopsy replace fine needle aspiration cytology in the diagnosis of palpable breast carcinoma: a comparative study of 124 women. ACS J. 1996;78(4):773.

Fattahi AS, Tavassoli A, Kalantari MR, Noorshafiee S, Rahmanin M. Evaluation of the value of core needle biopsy in the diagnosis of a breast mass. Arch Breast Cancer. 2016;3(2):56-61.

Hari S, Kumari S, Srivastava A, Thulkar S, Mathur S, Veedu PT. Image guided versus palpation guided core needle biopsy of palpable breast masses: a prospective study. Indian J Med Res. 2016;143(5):597-604.

Khanna S, Aryya NC, Khanna NN. Spectrum of benign breast disease. Indian J Surg. 1988;50:169.

Rangabashyam N, Gnanaprakasam D, Krishnaraj DB, Monohar V, Vijayalakshmi SR. Spectrum of benign breast lesions in Madras. J Roy Coll Surg. 1983;28:369.

Hackett TP, Cassem NH, Raker JW. Patient delay in cancer. N Engl J Med. 1973;289:14-20.

Adams SA, Homer JK, Vessey MP. Delay in treatment for breast cancer. Community Med. 1980;2:195-201.

Nichols S, Waters WE, Fraser JD. Delay in the presentation of breast symptoms for consultant investigation. Community Med. 1981;3:217-25.

Robinson E, Mohilever J, Borovick R. Factors affecting delay in diagnosis of breast cancer: relationship of delay to stage of disease. Israeli J Med Sci. 1986;22:333-6.

Elzawawy AM, Alaadeen ME, Dawood SM, Hussaam ME, Badran A. Delay in seeking medical advice and late presentation of female breast cancer patients in most of the world. Could we make changes? The experience of 23 years in Port Said, Egypt. Reast Care (Basel). 2008;3(1):37-41.